NM Tung

Statistics

Publications

Citations

H-Index

Active since

2011

Affiliations

Beth Israel Deaconess Medical Center(Current)

Dana-Farber Cancer Institute

NM Tung is an author at Beth Israel Deaconess Medical Center specializing in medicine, pharmacodynamics of anticancer agents, and metastatic breast cancer.

Publications per year

2011–2019

Publications

Is hormone replacement therapy (HRT) following risk-reducing salpingo-oophorectomy (RRSO) in BRCA1 (B1)- and BRCA2 (B2)-mutation carriers associated with an increased risk of breast cancer?

S. M. Domchek, Tara M. Friebel, Susan L. Neuhausen et al. · Journal of Clinical Oncology · 2011 · 21 citations

Medicine, Endocrinology, Gynecology +17

P3-16-05: A Phase II Trial Expansion Cohort of the PARP Inhibitor Veliparib (ABT888) and Temozolomide in BRCA1/2 Associated Metastatic Breast Cancer.

SJ Isakoff, Beth Overmoyer, NM Tung et al. · Cancer Research · 2011 · 19 citations

Medicine, Oncology, Pharmacology +15

Abstract PD1-05: Results from the phase Ib/II clinical trial of bazedoxifene and palbociclib in hormone receptor positive metastatic breast cancer

Rinath Jeselsohn, Hao Guo, Rebecca Rees et al. · Cancer Research · 2019 · 10 citations

Medicine, Oncology, Pharmacology +15

1–3 of 3